Alveo Technologies

Alveo Technologies is a company founded in 2020 headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Alveo Technologies develops a portable molecular diagnostic platform consisting of a palm-sized analyzer, preloaded test cartridges, and a smartphone app to deliver rapid, traceable pathogen detection at the point of need. Its system is used for applications in animal health (e.g., avian influenza), agriculture, public health, and bioprocessing quality control.